Skip to main content
OpenTrials

Clinical trial condition

Polycythemia Vera

Explore clinical trials studying Polycythemia Vera. Study availability and eligibility vary by location and protocol.

207 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Polycythemia Vera trial results

Active, Not Recruiting

A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera

NCT05210790

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Infirmary Cancer Care Mobile, Alabama, United States
  • Palo Verde Hematology-Oncology Glendale, Arizona, United States
  • City of Hope Medical Center, Duarte Duarte, California, United States
  • California Cancer Associates for Research and Excellence - Fresno Fresno, California, United States
View all 184 locations
View Trial Details
Active, Not Recruiting

A Study to Access Efficacy and Safety of P1101 in Chinese PV Patients Who Are Intolerant or Resistance to HU

NCT05485948

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Peking Union Medical College Hospital Beijing, China
  • Xiangya Hospital Central South University Changsha, China
  • The First Affiliated Hospital of Chongqing Medical Universit Chongqing, China
  • Nanfang Hospital affiliated to Southern Medical University Guangzhou, China
View all 14 locations
View Trial Details
Active, Not Recruiting

The Ruxo-BEAT Trial in Patients With High-risk Polycythemia Vera or High-risk Essential Thrombocythemia

NCT02577926

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
Locations
  • Universitätsmedizin Mannheim III. Medizinische Klinik Hämatologie und Internistische Onkologie Mannheim, Baden-Wurttemberg, Germany
  • Universitätsklinikum Ulm Klinik für Innere Medizin III Ulm, Baden-Wurttemberg, Germany
  • Rems-Murr Klinikum Winnenden Winnenden, Baden-Wurttemberg, Germany
  • Studienzentrum Aschaffenburg Aschaffenburg, Bavaria, Germany
View all 23 locations
View Trial Details
Active, Not Recruiting

Long-term Study Evaluating the Effect of Givinostat in Patients With Chronic Myeloproliferative Neoplasms

NCT01761968

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
Locations
  • Charite Research Organization GmbH Berlin, Germany
  • Universitaetsklinikum Freiburg, Innere Medizin I - Haematologie und Onkologie Freiburg im Breisgau, Germany
  • Azienda Ospedaliero-Universitaria Policlinico Consorziale, Bari Bari, BA, Italy
  • Istituto Tumori Giovanni Paolo II IRCCS Ospedale Oncologico di Bari Bari, BA, Italy
View all 15 locations
View Trial Details
Active, Not Recruiting

A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm

NCT04041050

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +22 more
Locations
  • City of Hope /ID# 239769 Duarte, California, United States
  • Providence - St. Jude Medical Center /ID# 242558 Fullerton, California, United States
  • Moores Cancer Center at UC San Diego /ID# 229584 La Jolla, California, United States
  • UCLA /Id# 222784 Los Angeles, California, United States
View all 42 locations
View Trial Details
Active, Not Recruiting

Unraveling the Role of Extracellular Vesicles-driven Senescence in Myeloproliferative Neoplasms

NCT06798805

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +15 more
Locations
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy
  • ASST Spedali Civili di Brescia Brescia, BS, Italy
  • Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori- IRST Meldola, FC, Italy
  • Ospedale S.Maria delle Croci Ravenna, RA, Italy
View Trial Details

Related conditions